Difference between revisions of "2017-04-13 Patient Care FHIR Call"

Revision as of 22:39, 12 April 2017

Patient Care FHIR Resources Conference Call Location: Conference Call Phone Number: +1 770-657-9270 Participant Passcode: 943377 WebEx: https://cernermeeting.webex.com/join/michelle.m.miller		Date: 2017-04-13 Time: 5-6:30pm ET
Facilitator	Michelle M Miller	Note taker(s)	Michelle M Miller

Attendee	Name	Affiliation
	Elaine Ayres	NIH/Department of Clinical Research Informatics
	Pushpalatha Bhat
	Stephen Chu	The Australian Digital Health Agency (ADHA)
	Evelyn Gallego	EMI Advisors LLC
	Eric Haas	Haas Consulting
	Rob Hausam	Hausam Consulting LLC
	Laura Heermann-Langford	Intermountain Healthcare
	Emma Jones	Allscripts
	Russ Leftwich	InterSystems
	Tony Little	Optum 360
	Jay Lyle	Ockham Information Services LLC, VA
	Russell McDonell	Telstra Health
	Lloyd McKenzie	Gevity (HL7 Canada)
	Larry McKnight	Cerner
	Michelle M Miller	Cerner
	Lisa Nelson	Life Over Time Solutions
	Viet Nguyen	Lockheed Martin, Systems Made Simple
	M'Lynda Owens	Cognosante
	Craig Parker	Intermountain Healthcare
	Joe Quinn	Optum
	Simon Sum	Academy of Nutrition and Dietetics
	Iona Thraen	Dept of Veterans Affairs
	Serafina Versaggi	Dept of Veterans Affairs

Quorum Requirements Met: yes

Agenda Topics

Agenda review
Approve previous meeting minutes 2017-04-06_Patient_Care_FHIR_Call
- Motion: <moved>/<seconded>
Prior Action Item Follow-up
gForge change request

Blood, Tissue, Organ Donation
- NMDP (National Marrow Donor Program) and CIBTMR (Center for International Blood and Marrow Transplant Research) would like to participate in helping develop a new resource for transplant material
- It would include things like bone marrow, cord blood, peripheral blood stem cells, solid organs, blood transfusion, etc
- Align with scope of ISBT128, the purpose of which is: to provide standards and guidance for the coding and labeling of medical products of human origin (MPHO): blood, cellular therapy, tissues, regenerated tissue, milk, fecal microbiota, topical products of human origin, in vivo diagnostic MPHO, and organs for transplant, as well as those plasma derivatives for which ABO is relevant. (we may want to extend the scope to “biological origin” rather than limiting to “human origin”)
- Previously, Patient Care had voted to create a new resource, per GF#8458

Adjourned at <hh:mm am/pm> <timezone>.

Actions

Next Meeting/Preliminary Agenda Items

Agenda review
Approve previous meeting minutes
- Motion: <moved>/<seconded> Abstain - <#>, Negative - <#>, Approve - <#>
gForge change request

@@ Line 167: / Line 167: @@
 <!-- **** Delete instructions  and fill in minutes ON NEXT LINES  ******-->
-=== Prior Action Item Follow-up ===
+=== Zulip ===
+* [https://chat.fhir.org/#narrow/stream/implementers/subject/Blood.2C.20Tissue.2C.20Organ.3A.20Donation Blood, Tissue, Organ Donation]
+** NMDP (National Marrow Donor Program) and CIBTMR (Center for International Blood and Marrow Transplant Research) would like to participate in helping develop a new resource for transplant material
+** It would include things like bone marrow, cord blood, peripheral blood stem cells, solid organs, blood transfusion, etc
+** Align with scope of ISBT128, the purpose of which is:  to provide standards and guidance for the coding and labeling of medical products of human origin (MPHO): blood, cellular therapy, tissues, regenerated tissue, milk, fecal microbiota, topical products of human origin, in vivo diagnostic MPHO, and organs for transplant, as well as those plasma derivatives for which ABO is relevant.  (we may want to extend the scope to “biological origin” rather than limiting to “human origin”)
+** Previously, Patient Care had voted to create a new resource, per [http://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=8458 GF#8458]
 === gForge Change Requests ===